Journal of Allergy and Clinical Immunology最新文献

筛选
英文 中文
Fine resolution of the N-terminal IgE-binding epitope of Ara h 2: discovery of variants with enhanced IgE binding. Ara h2 n端IgE结合表位的精细解析:发现具有增强IgE结合的变体。
IF 14.2 1区 医学
Journal of Allergy and Clinical Immunology Pub Date : 2025-04-29 DOI: 10.1016/j.jaci.2025.03.032
Joshua S Bernstein,Nicole Canon,Catherine H Schein,Werner Braun,Surendra S Negi,Raffi Tchekmedyian,Marina Pozzoli,Edwin H Kim,Michael D Kulis,Thao Vu,Weimin Liu,Xueni Chen,Stephen C Dreskin
{"title":"Fine resolution of the N-terminal IgE-binding epitope of Ara h 2: discovery of variants with enhanced IgE binding.","authors":"Joshua S Bernstein,Nicole Canon,Catherine H Schein,Werner Braun,Surendra S Negi,Raffi Tchekmedyian,Marina Pozzoli,Edwin H Kim,Michael D Kulis,Thao Vu,Weimin Liu,Xueni Chen,Stephen C Dreskin","doi":"10.1016/j.jaci.2025.03.032","DOIUrl":"https://doi.org/10.1016/j.jaci.2025.03.032","url":null,"abstract":"BACKGROUNDIgE binding to linear peptides from the N-terminal region of Ara h 2 (epitope 1) is associated with the achievement of sustained unresponsiveness (SU) in young children receiving oral immunotherapy (OIT) and may be important for cross-reactivity between peanuts and tree nuts. This region is also part of the binding site for neutralizing IgG monoclonal antibodies associated with SU following OIT.OBJECTIVETo perform alanine scanning of this epitope to determine the importance of individual amino acids and then amino acid scanning to screen for sequences with enhanced binding of IgE.METHODSA streptavidin IgE ELISA with biotinylated peptides was used to measure the binding of IgE to full length and truncated peptides in order to identify a core sequence (DRRCQSQLERAN). Peptide microarrays were used to screen multiple peptides and quantitate binding of IgE. Statistical analysis included one way ANOVA followed by Dunnett's multiple comparison test.RESULTSIgE binding was greatly reduced when alanine was substituted for arginine at positions 2, 3 and 10 (R2, P<0.001, R3, P<0.01, R10, P<0.001), glutamine at position 5 and 7 (Q5, P<0.01, Q7, P<0.001) and glutamate at position 9 (E9, P<0.01). Substitution of aspartate with asparagine at position 1 in conjunction with substitution of asparagine at position 12 with either leucine or lysine gave enhanced binding (p<0.0001). Molecular modeling of these data suggests a conformational basis for recognition by polyclonal IgE.CONCLUSIONSIgE binding assays using pooled and individual sera demonstrated the importance of aa throughout the sequence of epitope 1 for immune recognition. The results of alanine scanning indicated residues that could be changed as part of a larger strategy to generate hypoallergenic forms of Ara h 2 while sequence variants with enhanced binding were identified that may be useful for improving diagnostics.","PeriodicalId":14936,"journal":{"name":"Journal of Allergy and Clinical Immunology","volume":"92 1","pages":""},"PeriodicalIF":14.2,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143902888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply. 回复。
IF 11.4 1区 医学
Journal of Allergy and Clinical Immunology Pub Date : 2025-04-28 DOI: 10.1016/j.jaci.2025.03.031
Nandinee Patel, Paul J Turner
{"title":"Reply.","authors":"Nandinee Patel, Paul J Turner","doi":"10.1016/j.jaci.2025.03.031","DOIUrl":"https://doi.org/10.1016/j.jaci.2025.03.031","url":null,"abstract":"","PeriodicalId":14936,"journal":{"name":"Journal of Allergy and Clinical Immunology","volume":" ","pages":""},"PeriodicalIF":11.4,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144007174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Food allergy endotypes revisited. 重新审视食物过敏内源性类型。
IF 11.4 1区 医学
Journal of Allergy and Clinical Immunology Pub Date : 2025-04-28 DOI: 10.1016/j.jaci.2025.04.019
Mary Grace Baker, Lydia Su Yin Wong, George N Konstantinou, Anna Nowak-Wegrzyn
{"title":"Food allergy endotypes revisited.","authors":"Mary Grace Baker, Lydia Su Yin Wong, George N Konstantinou, Anna Nowak-Wegrzyn","doi":"10.1016/j.jaci.2025.04.019","DOIUrl":"10.1016/j.jaci.2025.04.019","url":null,"abstract":"<p><p>In the last century, food allergy has become recognized as an increasingly prevalent and heterogeneous condition. Advances in biomedical technology have revealed complex genetic, environmental, immune, and metabolic pathways underlying the pathogenesis of food-allergic disorders. These findings permit classification of distinct food allergy endotypes with unique pathophysiologic features. In this review, we suggest that these endotypes of food-allergic disorders should be defined on the basis of (1) whether or not the allergic antibody IgE plays an essential role in disease pathogenesis, (2) the molecular features of the allergen (protein vs carbohydrate), and (3) the molecular markers associated with prognosis, severity, or clinical presentation. Beyond these broad categories, additional subtypes with unique mechanistic characteristics are discussed.</p>","PeriodicalId":14936,"journal":{"name":"Journal of Allergy and Clinical Immunology","volume":" ","pages":""},"PeriodicalIF":11.4,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144025450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epinephrine delivery devices: Pharmacokinetics and pharmacodynamics. 肾上腺素输送装置:药代动力学和药效学。
IF 14.2 1区 医学
Journal of Allergy and Clinical Immunology Pub Date : 2025-04-28 DOI: 10.1016/j.jaci.2025.03.030
John M Kelso
{"title":"Epinephrine delivery devices: Pharmacokinetics and pharmacodynamics.","authors":"John M Kelso","doi":"10.1016/j.jaci.2025.03.030","DOIUrl":"https://doi.org/10.1016/j.jaci.2025.03.030","url":null,"abstract":"","PeriodicalId":14936,"journal":{"name":"Journal of Allergy and Clinical Immunology","volume":"91 1","pages":""},"PeriodicalIF":14.2,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143889320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lessons from the clinical use of ex vivo T-lymphopoiesis assays. 体外t淋巴生成试验临床应用的经验教训。
IF 14.2 1区 医学
Journal of Allergy and Clinical Immunology Pub Date : 2025-04-28 DOI: 10.1016/j.jaci.2025.04.008
Grace Evans,Zainab M Golwala,Juan Moises Ocampo-Godinez,Alexandra Y Kreins
{"title":"Lessons from the clinical use of ex vivo T-lymphopoiesis assays.","authors":"Grace Evans,Zainab M Golwala,Juan Moises Ocampo-Godinez,Alexandra Y Kreins","doi":"10.1016/j.jaci.2025.04.008","DOIUrl":"https://doi.org/10.1016/j.jaci.2025.04.008","url":null,"abstract":"","PeriodicalId":14936,"journal":{"name":"Journal of Allergy and Clinical Immunology","volume":"9 1","pages":""},"PeriodicalIF":14.2,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143889308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complement dysregulation at lymphatics. 淋巴的补体失调。
IF 11.4 1区 医学
Journal of Allergy and Clinical Immunology Pub Date : 2025-04-27 DOI: 10.1016/j.jaci.2025.04.020
Ahmet Ozen, Salim Can, Asena Pinar Sefer, Necmiye Keser Ozturk, Burkay Cagan Colak
{"title":"Complement dysregulation at lymphatics.","authors":"Ahmet Ozen, Salim Can, Asena Pinar Sefer, Necmiye Keser Ozturk, Burkay Cagan Colak","doi":"10.1016/j.jaci.2025.04.020","DOIUrl":"10.1016/j.jaci.2025.04.020","url":null,"abstract":"<p><p>The complement system is a central component of innate immunity, orchestrating pathogen clearance while regulating inflammation, tissue repair, and homeostasis. Its activation is tightly controlled by multiple inhibitors to prevent self-damage. However, complement dysregulation is implicated in numerous organ-specific diseases, including paroxysmal nocturnal hemoglobinuria (erythrocytes), atypical hemolytic uremic syndrome (kidneys), and age-related macular degeneration (eyes). Recent discoveries have revealed that complement hyperactivation also drives lymphatic dysfunction, most notably in CHAPLE (CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy) disease-a rare pediatric disorder caused by biallelic CD55 mutations. Impaired regulation of C3 and C5 convertases leads to unchecked complement and coagulation activation, resulting in membrane attack complex deposition, severe intestinal lymphangiectasia, and protein-losing enteropathy. Patients typically present with hypoalbuminemia, edema, gastrointestinal symptoms, growth retardation, and recurrent thromboembolic events, reflecting a severe thrombophilic phenotype. C5-blocking antibodies, including pozelimab and eculizumab, transformed CHAPLE management. In a phase 2/3 study, pozelimab led to normalization of serum albumin levels and notable reductions in hospitalizations and transfusion needs, leading to Food and Drug Administration approval. Emerging evidence suggests that complement-driven protein-losing enteropathy may also arise in other pathological contexts, expanding the clinical impact of complement dysregulation. As research progresses, novel diagnostic and therapeutic strategies are expected to emerge for a broader spectrum of complement-mediated lymphatic disorders.</p>","PeriodicalId":14936,"journal":{"name":"Journal of Allergy and Clinical Immunology","volume":" ","pages":""},"PeriodicalIF":11.4,"publicationDate":"2025-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144025907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Probing the diagnosis of SCID through in vitro T-cell development: experience in two centers in North America. 通过体外t细胞发育探讨SCID的诊断:北美两个中心的经验。
IF 14.2 1区 医学
Journal of Allergy and Clinical Immunology Pub Date : 2025-04-26 DOI: 10.1016/j.jaci.2025.04.021
Clara Soulard,Francesca Pala,Marita Bosticardo,Elie Haddad
{"title":"Probing the diagnosis of SCID through in vitro T-cell development: experience in two centers in North America.","authors":"Clara Soulard,Francesca Pala,Marita Bosticardo,Elie Haddad","doi":"10.1016/j.jaci.2025.04.021","DOIUrl":"https://doi.org/10.1016/j.jaci.2025.04.021","url":null,"abstract":"","PeriodicalId":14936,"journal":{"name":"Journal of Allergy and Clinical Immunology","volume":"222 1","pages":""},"PeriodicalIF":14.2,"publicationDate":"2025-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143889293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selective JAK1 inhibition remits multiorgan autoimmunity in a patient with refractory autoimmune polyendocrine syndrome type 1. 选择性JAK1抑制缓解难治性自身免疫性多内分泌综合征1型患者的多器官自身免疫
IF 14.2 1区 医学
Journal of Allergy and Clinical Immunology Pub Date : 2025-04-24 DOI: 10.1016/j.jaci.2025.03.026
Yannis Hadjiyannis,Madison N Martinez,Joseph Pechacek,Ibrahim Abukhiran,Deanna Riley,Stefania Pittaluga,Elena M Morariu,Michail S Lionakis,David G Binion,Reed Van Deusen
{"title":"Selective JAK1 inhibition remits multiorgan autoimmunity in a patient with refractory autoimmune polyendocrine syndrome type 1.","authors":"Yannis Hadjiyannis,Madison N Martinez,Joseph Pechacek,Ibrahim Abukhiran,Deanna Riley,Stefania Pittaluga,Elena M Morariu,Michail S Lionakis,David G Binion,Reed Van Deusen","doi":"10.1016/j.jaci.2025.03.026","DOIUrl":"https://doi.org/10.1016/j.jaci.2025.03.026","url":null,"abstract":"","PeriodicalId":14936,"journal":{"name":"Journal of Allergy and Clinical Immunology","volume":"1 1","pages":""},"PeriodicalIF":14.2,"publicationDate":"2025-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143872022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clarification of the efficacy of tezepelumab in the phase 2a COURSE trial. 澄清tezepelumab在2a期COURSE试验中的疗效。
IF 14.2 1区 医学
Journal of Allergy and Clinical Immunology Pub Date : 2025-04-23 DOI: 10.1016/j.jaci.2024.12.1086
Dave Singh,MeiLan K Han,Jean-Pierre Llanos,Neil Martin,Amit Parulekar,Konstantinos Kostikas,Sandhia S Ponnarambil
{"title":"Clarification of the efficacy of tezepelumab in the phase 2a COURSE trial.","authors":"Dave Singh,MeiLan K Han,Jean-Pierre Llanos,Neil Martin,Amit Parulekar,Konstantinos Kostikas,Sandhia S Ponnarambil","doi":"10.1016/j.jaci.2024.12.1086","DOIUrl":"https://doi.org/10.1016/j.jaci.2024.12.1086","url":null,"abstract":"","PeriodicalId":14936,"journal":{"name":"Journal of Allergy and Clinical Immunology","volume":"32 1","pages":""},"PeriodicalIF":14.2,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143866831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabotypes are linked to uncontrolled childhood asthma, gut microbiota, and systemic inflammation. 代谢型与不受控制的儿童哮喘、肠道微生物群和全身性炎症有关。
IF 14.2 1区 医学
Journal of Allergy and Clinical Immunology Pub Date : 2025-04-23 DOI: 10.1016/j.jaci.2025.04.017
Mahmoud I Abdel-Aziz,Simone Hashimoto,Anne H Neerincx,Eric G Haarman,Alexander Cecil,Jutta Lintelmann,Michael Witting,Stefanie M Hauck,Nikki Kerssemakers,Joris C Verster,Corinna Bang,Andre Franke,Barbara S Dierdorp,Tamara Dekker,Nariman K A Metwally,Jan Willem Duitman,René Lutter,Mario Gorenjak,Antoaneta A Toncheva,Parastoo Kheiroddin,Susanne Harner,Susanne Brandstetter,Christine Wolff,Paula Corcuera-Elosegui,Leyre López-Fernández,Javier Perez-Garcia,Mario Martin Almeida,Olaia Sardón-Prado,Maria Pino-Yanes,Uroš Potočnik,Michael Kabesch,Susanne J H Vijverberg,Aletta D Kraneveld,Anke H Maitland-van der Zee,
{"title":"Metabotypes are linked to uncontrolled childhood asthma, gut microbiota, and systemic inflammation.","authors":"Mahmoud I Abdel-Aziz,Simone Hashimoto,Anne H Neerincx,Eric G Haarman,Alexander Cecil,Jutta Lintelmann,Michael Witting,Stefanie M Hauck,Nikki Kerssemakers,Joris C Verster,Corinna Bang,Andre Franke,Barbara S Dierdorp,Tamara Dekker,Nariman K A Metwally,Jan Willem Duitman,René Lutter,Mario Gorenjak,Antoaneta A Toncheva,Parastoo Kheiroddin,Susanne Harner,Susanne Brandstetter,Christine Wolff,Paula Corcuera-Elosegui,Leyre López-Fernández,Javier Perez-Garcia,Mario Martin Almeida,Olaia Sardón-Prado,Maria Pino-Yanes,Uroš Potočnik,Michael Kabesch,Susanne J H Vijverberg,Aletta D Kraneveld,Anke H Maitland-van der Zee,","doi":"10.1016/j.jaci.2025.04.017","DOIUrl":"https://doi.org/10.1016/j.jaci.2025.04.017","url":null,"abstract":"BACKGROUNDChildhood asthma has been linked to distinct metabolomic profiles.OBJECTIVETo identify phenotypes (metabotypes) in children with moderate-to-severe asthma through integrative fecal and serum metabolome analysis.METHODSChildren from the Systems Pharmacology Approach to Uncontrolled Pediatric Asthma cohort with Global Initiative for Asthma treatment step ≥3 were recruited. Asthma control was defined by the Asthma Control Test and annual exacerbation history. Targeted metabolomics profiling of feces and serum was performed using liquid chromatography and flow injection electrospray ionization-triple quadrupole mass spectrometry. Similarity Network Fusion integrated fecal and serum metabolome profiles, followed by spectral clustering. Clusters were analyzed for differences in asthma characteristics, food diaries, fecal microbiota composition, and levels of serum inflammatory markers and blood cells.RESULTSIntegrative fecal and serum metabolome analysis of 92 children with moderate-to-severe asthma (median age: 11.5 years, 34% female) revealed three metabotypes. Metabotype1 had the lowest percentage of allergic rhinitis, with elevated serum ceramides and triglycerides. Metabotype2 had higher odds of asthma control, the highest percentage of children with ≥4 months of breastfeeding, reduced sugar intake, lowest levels of blood neutrophils and serum inflammatory markers, and with elevated serum acylcarnitines and ω-3 fatty acids. Metabotype3 included the highest percentage of uncontrolled asthma patients, with decreased serum cholesteryl esters, phosphatidylcholines, and sphingomyelins, elevated fecal amino acids, and reduced fecal microbiota diversity.CONCLUSIONSMetabotypes in children with moderate-to-severe asthma are linked to asthma control, distinct fecal microbiota and systemic inflammatory patterns. The findings suggest that metabotyping can be valuable in precision medicine approaches for asthma.","PeriodicalId":14936,"journal":{"name":"Journal of Allergy and Clinical Immunology","volume":"19 1","pages":""},"PeriodicalIF":14.2,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143884939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信